---
schema_version: "secwatch.filing_event.v1"
accession: "0001178913-25-001308"
form_type: "8-K"
ticker: "LFWD"
cik: "0001607962"
company_name: "Lifeward Ltd."
filed_at: "2025-04-15T23:59:59+00:00"
generated_at: "2026-05-23T14:40:43.524486+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Lifeward launches ReWalk 7 Personal Exoskeleton for U.S. market

## Summary
- ReWalk 7 now available nationwide for individuals with spinal cord injury.
- New features: cloud connectivity, customizable speeds, crutch control, smartwatch app.
- FDA clearance received in March 2025; CMS Medicare reimbursement pathway established in 2024.
- Device tested with over two dozen users and therapists pre-launch.
- Improved battery and stair/curb navigation enhance real-world usability.

## SEC filing metadata
- accession: 0001178913-25-001308
- form_type: 8-K
- ticker: LFWD
- cik: 0001607962
- company_name: Lifeward Ltd.
- filed_at: 2025-04-15T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1607962/000117891325001308/0001178913-25-001308-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1607962/000117891325001308/zk2533011.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001178913-25-001308
- JSON: https://secwatch.observer/filing/0001178913-25-001308.json
- Plain text: https://secwatch.observer/filing/0001178913-25-001308.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.